Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Cangnuo Biotechnology is a Chinese biotechnology company headquartered in Shijiazhuang, Hebei Province, that specializes in the research, development, and distribution of pharmaceutical intermediates and fine chemicals. The company primarily focuses on the production of high-purity biochemical ingredients such as Nicotinamide Mononucleotide (NMN), Glutathione, and various coenzymes used in the health supplement and cosmetic sectors. Operating as a manufacturer and global supplier, they provide raw materials to pharmaceutical and nutraceutical companies worldwide. Their business operations emphasize quality management and the scaling of biochemical synthesis processes to meet international standards. The company serves as a key link in the global supply chain for anti-aging and nutritional health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Cangnuo Biotechnology.